Fresenius Kabi, revenue | Number of Estimates | | | 11 | 11 | 10 |
Fresenius Kabi, revenue | Highest | | | 2,191.2 | 8,457.2 | 9,107.3 |
Fresenius Kabi, revenue | Consensus (Mean) | 1,996.0 | 8,009.0 | 2,132.4 | 8,398.4 | 8,971.6 |
Fresenius Kabi, revenue | Median | | | 2,133.9 | 8,399.9 | 8,967.7 |
Fresenius Kabi, revenue | Lowest | | | 2,063.0 | 8,329.0 | 8,827.0 |
Fresenius Kabi, organic revenue growth (in %) | Number of Estimates | | | 6 | 9 | 9 |
Fresenius Kabi, organic revenue growth (in %) | Highest | | | 10.0 | 10.2 | 7.7 |
Fresenius Kabi, organic revenue growth (in %) | Consensus (Mean) | 7.0 | 7.0 | 7.4 | 9.7 | 6.7 |
Fresenius Kabi, organic revenue growth (in %) | Median | | | 7.0 | 9.6 | 6.9 |
Fresenius Kabi, organic revenue growth (in %) | Lowest | | | 5.9 | 9.3 | 5.6 |
thereof Medtech, revenue | Number of Estimates | | | 8 | 8 | 8 |
thereof Medtech, revenue | Highest | | | 436.9 | 1,581.9 | 1,730.5 |
thereof Medtech, revenue | Consensus (Mean) | 397.0 | 1,510.0 | 415.5 | 1,560.5 | 1,673.0 |
thereof Medtech, revenue | Median | | | 419.3 | 1,564.3 | 1,673.5 |
thereof Medtech, revenue | Lowest | | | 385.4 | 1,530.4 | 1,608.9 |
thereof Nutrition, revenue | Number of Estimates | | | 8 | 8 | 8 |
thereof Nutrition, revenue | Highest | | | 659.3 | 2,445.3 | 2,577.3 |
thereof Nutrition, revenue | Consensus (Mean) | 501.0 | 2,304.0 | 564.4 | 2,350.4 | 2,503.3 |
thereof Nutrition, revenue | Median | | | 545.2 | 2,331.2 | 2,510.9 |
thereof Nutrition, revenue | Lowest | | | 526.3 | 2,312.3 | 2,413.2 |
thereof Biopharma, revenue | Number of Estimates | | | 8 | 8 | 8 |
thereof Biopharma, revenue | Highest | | | 195.2 | 661.2 | 876.3 |
thereof Biopharma, revenue | Consensus (Mean) | 99.0 | 363.0 | 165.2 | 631.2 | 799.8 |
thereof Biopharma, revenue | Median | | | 160.8 | 626.8 | 797.5 |
thereof Biopharma, revenue | Lowest | | | 137.0 | 603.0 | 740.4 |
Subtotal Growth Vectors, revenue | Number of Estimates | | | 8 | 8 | 8 |
Subtotal Growth Vectors, revenue | Highest | | | 1,241.0 | 4,637.0 | 5,082.9 |
Subtotal Growth Vectors, revenue | Consensus (Mean) | 997.0 | 4,177.0 | 1,146.1 | 4,542.1 | 4,976.1 |
Subtotal Growth Vectors, revenue | Median | | | 1,127.7 | 4,523.7 | 4,981.4 |
Subtotal Growth Vectors, revenue | Lowest | | | 1,108.0 | 4,504.0 | 4,883.5 |
Pharma (IV Drugs & Fluids), revenue | Number of Estimates | | | 8 | 8 | 8 |
Pharma (IV Drugs & Fluids), revenue | Highest | | | 1,076.1 | 3,946.1 | 4,095.0 |
Pharma (IV Drugs & Fluids), revenue | Consensus (Mean) | 1,000.0 | 3,832.0 | 1,006.8 | 3,876.8 | 4,025.8 |
Pharma (IV Drugs & Fluids), revenue | Median | | | 1,004.7 | 3,874.7 | 4,035.0 |
Pharma (IV Drugs & Fluids), revenue | Lowest | | | 933.2 | 3,803.2 | 3,932.2 |
Fresenius Kabi, EBIT | Number of Estimates | | | 11 | 11 | 10 |
Fresenius Kabi, EBIT | Highest | | | 342.8 | 1,321.8 | 1,522.2 |
Fresenius Kabi, EBIT | Consensus (Mean) | 282.0 | 1,145.0 | 330.5 | 1,309.5 | 1,457.3 |
Fresenius Kabi, EBIT | Median | | | 333.1 | 1,312.1 | 1,459.7 |
Fresenius Kabi, EBIT | Lowest | | | 318.0 | 1,297.0 | 1,393.2 |
Fresenius Kabi, EBIT margin | Number of Estimates | | | 11 | 11 | 10 |
Fresenius Kabi, EBIT margin | Highest | | | 16.3 | 15.8 | 16.8 |
Fresenius Kabi, EBIT margin | Consensus (Mean) | 14.1 | 14.3 | 15.5 | 15.6 | 16.2 |
Fresenius Kabi, EBIT margin | Median | | | 15.5 | 15.6 | 16.3 |
Fresenius Kabi, EBIT margin | Lowest | | | 14.8 | 15.4 | 15.5 |
thereof Growth Vectors, EBIT | Number of Estimates | | | 8 | 8 | 8 |
thereof Growth Vectors, EBIT | Highest | | | 176.6 | 637.6 | 769.9 |
thereof Growth Vectors, EBIT | Consensus (Mean) | 102.0 | 390.0 | 144.1 | 605.1 | 728.6 |
thereof Growth Vectors, EBIT | Median | | | 155.4 | 616.4 | 748.0 |
thereof Growth Vectors, EBIT | Lowest | | | 39.9 | 500.9 | 574.2 |
thereof Growth Vectors, EBIT margin (in %) | Number of Estimates | | | 8 | 8 | 8 |
thereof Growth Vectors, EBIT margin (in %) | Highest | | | 14.9 | 13.9 | 15.6 |
thereof Growth Vectors, EBIT margin (in %) | Consensus (Mean) | 10.2 | 9.3 | 12.5 | 13.3 | 14.6 |
thereof Growth Vectors, EBIT margin (in %) | Median | | | 13.8 | 13.6 | 14.9 |
thereof Growth Vectors, EBIT margin (in %) | Lowest | | | 3.6 | 11.1 | 11.8 |
thereof Pharma (IV Drugs & Fluids), EBIT | Number of Estimates | | | 8 | 8 | 8 |
thereof Pharma (IV Drugs & Fluids), EBIT | Highest | | | 226.5 | 799.5 | 853.5 |
thereof Pharma (IV Drugs & Fluids), EBIT | Consensus (Mean) | 189.0 | 792.0 | 196.6 | 769.6 | 802.0 |
thereof Pharma (IV Drugs & Fluids), EBIT | Median | | | 193.7 | 766.7 | 795.9 |
thereof Pharma (IV Drugs & Fluids), EBIT | Lowest | | | 176.9 | 749.9 | 766.1 |
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %) | Number of Estimates | | | 8 | 8 | 8 |
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %) | Highest | | | 22.0 | 20.5 | 21.0 |
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %) | Consensus (Mean) | 18.9 | 20.7 | 19.5 | 19.9 | 19.9 |
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %) | Median | | | 19.3 | 19.8 | 20.0 |
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %) | Lowest | | | 18.2 | 19.5 | 18.7 |
thereof Corporate, EBIT | Number of Estimates | | | 7 | 7 | 7 |
thereof Corporate, EBIT | Highest | | | -9.0 | -64.0 | -65.9 |
thereof Corporate, EBIT | Consensus (Mean) | -10.0 | -37.0 | -18.0 | -73.0 | -78.7 |
thereof Corporate, EBIT | Median | | | -20.0 | -75.0 | -83.0 |
thereof Corporate, EBIT | Lowest | | | -26.4 | -81.4 | -88.0 |
Fresenius Helios, revenue | Number of Estimates | | | 11 | 11 | 10 |
Fresenius Helios, revenue | Highest | | | 3,332.9 | 12,798.9 | 13,471.3 |
Fresenius Helios, revenue | Consensus (Mean) | 3,092.0 | 11,952.0 | 3,218.6 | 12,684.6 | 13,327.5 |
Fresenius Helios, revenue | Median | | | 3,226.3 | 12,692.3 | 13,343.6 |
Fresenius Helios, revenue | Lowest | | | 3,065.3 | 12,531.3 | 13,169.1 |
Fresenius Helios, organic revenue growth (in %) | Number of Estimates | | | 6 | 9 | 9 |
Fresenius Helios, organic revenue growth (in %) | Highest | | | 6.0 | 6.6 | 5.3 |
Fresenius Helios, organic revenue growth (in %) | Consensus (Mean) | 5.0 | 5.0 | 4.6 | 6.0 | 5.0 |
Fresenius Helios, organic revenue growth (in %) | Median | | | 5.0 | 6.0 | 5.1 |
Fresenius Helios, organic revenue growth (in %) | Lowest | | | 2.8 | 5.5 | 4.1 |
Helios Germany, revenue | Number of Estimates | | | 8 | 8 | 8 |
Helios Germany, revenue | Highest | | | 1,918.0 | 7,643.0 | 7,996.3 |
Helios Germany, revenue | Consensus (Mean) | 1,828.0 | 7,279.0 | 1,895.4 | 7,620.4 | 7,933.7 |
Helios Germany, revenue | Median | | | 1,900.7 | 7,625.7 | 7,924.8 |
Helios Germany, revenue | Lowest | | | 1,863.4 | 7,588.4 | 7,891.9 |
Helios Spain, revenue | Number of Estimates | | | 8 | 8 | 8 |
Helios Spain, revenue | Highest | | | 1,428.4 | 5,169.4 | 5,534.4 |
Helios Spain, revenue | Consensus (Mean) | 1,265.0 | 4,672.0 | 1,331.8 | 5,072.8 | 5,397.3 |
Helios Spain, revenue | Median | | | 1,338.7 | 5,079.7 | 5,416.0 |
Helios Spain, revenue | Lowest | | | 1,183.8 | 4,924.8 | 5,269.5 |
Fresenius Helios, EBIT | Number of Estimates | | | 11 | 11 | 10 |
Fresenius Helios, EBIT | Highest | | | 379.0 | 1,328.0 | 1,411.8 |
Fresenius Helios, EBIT | Consensus (Mean) | 356.0 | 1,190.0 | 338.3 | 1,287.3 | 1,338.3 |
Fresenius Helios, EBIT | Median | | | 338.7 | 1,287.7 | 1,343.1 |
Fresenius Helios, EBIT | Lowest | | | 302.0 | 1,251.0 | 1,250.2 |
Fresenius Helios, EBIT margin (in %) | Number of Estimates | | | 11 | 11 | 10 |
Fresenius Helios, EBIT margin (in %) | Highest | | | 11.5 | 10.4 | 10.6 |
Fresenius Helios, EBIT margin (in %) | Consensus (Mean) | 11.5 | 10.0 | 10.5 | 10.1 | 10.0 |
Fresenius Helios, EBIT margin (in %) | Median | | | 10.3 | 10.1 | 10.1 |
Fresenius Helios, EBIT margin (in %) | Lowest | | | 9.4 | 9.9 | 9.3 |
Helios Germany, EBIT | Number of Estimates | | | 8 | 8 | 8 |
Helios Germany, EBIT | Highest | | | 167.3 | 699.3 | 727.8 |
Helios Germany, EBIT | Consensus (Mean) | 164.0 | 630.0 | 146.4 | 678.4 | 672.3 |
Helios Germany, EBIT | Median | | | 145.5 | 677.5 | 667.3 |
Helios Germany, EBIT | Lowest | | | 122.8 | 654.8 | 595.2 |
Helios Spain, EBIT | Number of Estimates | | | 8 | 8 | 8 |
Helios Spain, EBIT | Highest | | | 213.1 | 631.1 | 709.5 |
Helios Spain, EBIT | Consensus (Mean) | 184.0 | 564.0 | 197.5 | 615.5 | 673.1 |
Helios Spain, EBIT | Median | | | 195.4 | 613.4 | 671.3 |
Helios Spain, EBIT | Lowest | | | 173.0 | 591.0 | 638.8 |
Helios Corporate, EBIT | Number of Estimates | | | 8 | 8 | 8 |
Helios Corporate, EBIT | Highest | | | 0.0 | -1.0 | 0.0 |
Helios Corporate, EBIT | Consensus (Mean) | 8.0 | -4.0 | -2.9 | -3.9 | -4.2 |
Helios Corporate, EBIT | Median | | | -3.0 | -4.0 | -4.1 |
Helios Corporate, EBIT | Lowest | | | -10.0 | -11.0 | -15.0 |
Corporate/Other, revenue | Number of Estimates | | | 11 | 11 | 10 |
Corporate/Other, revenue | Highest | | | 332.0 | 600.0 | 618.0 |
Corporate/Other, revenue | Consensus (Mean) | 88.0 | 346.0 | 108.0 | 376.0 | 403.0 |
Corporate/Other, revenue | Median | | | 88.4 | 356.4 | 367.1 |
Corporate/Other, revenue | Lowest | | | 47.1 | 315.1 | 320.0 |
Corporate/Other, EBIT | Number of Estimates | | | 10 | 10 | 9 |
Corporate/Other, EBIT | Highest | | | -4.0 | -89.0 | -122.4 |
Corporate/Other, EBIT | Consensus (Mean) | -30.0 | -69.0 | -35.1 | -120.1 | -172.8 |
Corporate/Other, EBIT | Median | | | -35.5 | -120.5 | -180.0 |
Corporate/Other, EBIT | Lowest | | | -65.0 | -150.0 | -225.0 |